? to
maintain|385630006
fluid balance,|251856003

? to
defend
the body|279495008|123037004
against disease|64572001
by producing lymphocytes,|56972008|446325007
and

?
to
absorb
fats|256674009
and
fat soluble vitamins|35733004
(A,
D,|876000
E,
and
K
)
from the small intestine|264196002|181250005
and
transport|57188001|360300001
them
to the blood,|87612001|119273009
bypassing
the liver.|10200004|181268008

Lymphangiomatosis,|403546006
like other lymphatic malformations,|74964007|234095009
is
thought to|88952004
be
the result|394617004
of congenital errors|6160004|255399007
of lymphatic development|83555006|278923009
occurring|272120004
prior to the 20th week|258705008|259038000
of gestation.|289908002

Lymphangiomatosis|403546006
is
a condition|260905004
marked|46998006
by the presence|386397008
of cysts|441457006
that
result|394617004
from an increase|260366006
both
in the size|277049003
and
number|410680006|410681005
of thin-walled lymphatic channels|18043004|68947003|83555006|255592004
that
are
abnormally
interconnected
and
dilated.|255381004

[2] [3]|260306008
The condition|260905004
may
involve|248448006
a single organ system|125681006|91689009|50607009|91689009
;
75%
of cases|398241000|413769002
involve|248448006
multiple organs.|260396001|410653004

It typically
presents|52101004|246105001
by age 20|424144002
and
,
although
it
is
technically benign,|30807003
these deranged lymphatics|89890002|83555006
tend
to
invade
surrounding tissues|355648006|85756007
and
cause problems|134198009|55607006
due to invasion|370052007
and/or
compression|71173004|263720003
of adjacent structures.|18769003

[4]|260308009
The condition|260905004
is
most common|4757001|72906007
in the bones|272673000|128530007
and
lungs[1] [4]|39607008
and
shares
some characteristics
with Gorham?s disease.|1515008

Up to 75%
of patients|116154003
with lymphangiomatosis|403546006
have
bone involvement,|272673000|248448006|3138006|248448006|90780006|248448006|128530007|248448006
leading|236874000
some to
conclude
that lymphangiomatosis|403546006
and
Gorham?s disease|1515008
should
be
considered
as a spectrum
of disease|64572001
rather than
separate diseases.|263869007|64572001

[5]|264706000|264605009
When
it
occurs|272120004
in the lungs,|39607008
lymphangiomatosis|403546006
has
serious consequences|42745003|103332005
and
is
most aggressive|4757001|61372001|4757001
in the youngest children.|74489007

[3]|260313008
When
the condition|260905004
extends|255590007
into the chest|261179002
it commonly
results|394617004
in the accumulation
of chyle|18368008
in the linings|50009006
of the heart|80891009|302509004
and/or
lungs.|39607008

[3] Chyle|260313008|18368008
is
composed
of lymph fluid|38000004
and
fats|256674009
that
are
absorbed
from the small intestine|264196002|181250005
by specialized lymphatic vessels|67995009|83555006|83555006
called
lacteals|85528004
during digestion.|106079008

The accumulations
are
described
based|418836005
on location|246267002
:
chylothorax|83035003
is
chyle|18368008
in the chest|261179002
;
chylopericardium|233890005
is
chyle|18368008
trapped|403833009
inside the sack
surrounding|355648006
the heart|80891009|302509004
;
chyloascites
is
chyle|18368008
trapped|403833009
in the linings|50009006
of the abdomen|277112006|52731004|302553009
and
abdominal organs.|272631008

The presence|386397008
of chyle|18368008
in these places|257557008
accounts
for many|260396001
of the symptoms
and
complications|116223007
associated|47429007
with
both
lymphangiomatosis|403546006
and
Gorham?s disease.|1515008

[1] [6]|260305007
The incidence
of lymphangiomatosis|403546006
is
unknown|261665006
and
it
is
often|70232002
misdiagnosed.

It
is
separate|263869007
and
distinct
from lymphangiectasis,|238801004
lymphangioleiomyomatosis (LAM),|73017001
pulmonary capillary hemangiomatosis,|233949008
Kaposi?s sarcoma,|109385007
and
kaposiform hemangioendothelioma.|403983000

Its unusual nature|277302009
makes
lymphangiomatosis|403546006
(
and
Gorham?s disease|1515008
)
a diagnostic|439401001|261004008
and
therapeutic challenge.|262202000

[7]
A multidisciplinary approach
is
generally necessary
for optimal diagnosis|439401001
and
symptom management.|103735009

Lymphangiomatosis|403546006
is
a multi-system disorder.|260396001|370117001

Symptoms
depend
on the organ system|91689009
involved|248448006
and
,
to varying degrees,|246173007
the extent|255590007
of the disease.|64572001

Early|264499004
in the course|288524001
of the disease patients|64572001|116154003
are
usually asymptomatic,|84387000
but
over time|410669006
the abnormally
proliferating
lymphatic channels|83555006|255592004
that
constitute
lymphangiomatosis|403546006
are
capable
of massive expansion|46998006
and
infiltration|47351003|231287002
into surrounding tissues,|355648006|85756007
bone,|272673000|3138006|90780006|128530007
and
organs.|410653004

[4]|260308009
Because of its slow course|419443000|288524001
and
often vague symptoms,|70232002|248283007
the condition|260905004
is
frequently under-recognized|70232002
or
misdiagnosed.

[8]

Early signs|264499004|72670004
of disease|64572001
in the chest|261179002
include|55919000
wheezing, cough,|56018004|272039006
and
feeling|285854004
short of breath,|11891009
which
is
often|70232002
misdiagnosed
as asthma.|195967001

The pain|22253000
that
accompanies
bone involvement|272673000|248448006|3138006|248448006|90780006|248448006|128530007|248448006
may
be
attributed|246061005
to ?growing pains?|102482005
in younger children.|74489007

With bone involvement|272673000|248448006|3138006|248448006|90780006|248448006|128530007|248448006
the first indication|255216001|410666004|232714002|410666004
for disease|64572001
may
be
a pathological fracture.|268029009

Symptoms
may
not
raise|260399008
concern,
or
even
be
noted
,
until
the disease process|64572001|415178003
has
advanced|86005002
to a point
where it
causes|134198009
restrictive compression|71173004|263720003
of vital structures.|260410005

Further,|46053002
the occurrence|272120004
of chylous effusions|23839001
seems
to
be
unrelated|262241003
to the pathologic ?burden?|29458008
of the disease,|64572001
the extent|255590007
of involvement|248448006
in any particular tissue|85756007
or
organ,|410653004
or
the age|424144002
of the patient.|116154003

This offers one explanation|421379005
as to
why,
unfortunately,
the appearance|386548000|255412001
of chylous effusions|23839001
in the chest|261179002
or
abdomen|277112006|52731004|302553009
may
be
the first evidence|255216001|18669006|232714002|18669006
of the disease.|64572001

Following|255260001
are
some
of the commonly reported symptoms|229059009|223458004
of lymphangiomatosis,|403546006
divided|422033008
into the regions/systems|410673009|246333005
in which
the disease|64572001
occurs|272120004
:

?
*
*CARDIOTHORACIC
*
* ? Symptoms
that
arise|68727004
from disease|64572001
of the cardiothoracic region|410673009
include|55919000
a chronic cough,|68154008
wheezing,|56018004
dyspnea|267036007
(shortness|359530003|367450005
of breath|11891009
)?especially serious|42745003
when
occurring|272120004
at rest|258157001
or
when
lying|40199007|255576009
down?fever,|386661006
chest pain,|29857009
rapid heartbeat,|3424008
dizziness,|404640003|399153001
anxiety,|48694002|197480006
and
coughing|272039006
up blood|87612001|119273009
or
chyle.|18368008

As the deranged lymphatic vessels|83555006
invade
the organs|410653004
and
tissues|85756007
in the chest|261179002
they
put
stress|262188008
on the heart|80891009|302509004
and
lungs,|39607008
interfering|78235001
with their ability to|371150009
function|246464006
normally.

Additionally,
these lymphatic vessels|83555006
may
leak|87952002
,
allowing
fluid to|32457005|33463005|255765007
accumulate
in the chest,|261179002
which
puts
further|46053002
pressure|279046003|13543005|257893003
on the vital organs,|260410005|410653004
thus
increasing|260369004
their inability to
function|246464006
properly.

[1] [4] Accumulations|260305007
of fluid|32457005|33463005|255765007
and
chyle|18368008
are
named|27468005
based|418836005
on their contents|276824008
and
location|246267002
:
pulmonary edema|19242006
(
the presence|386397008
of fluid|32457005|33463005|255765007
and/or
chyle|18368008
in the lung|39607008|181216001
)
,
pleural effusions|60046008
(fluid|32457005|33463005|255765007
in the lung lining|39607008|50009006|181216001|50009006
)
,
pericardial effusions|373945007
(fluid|32457005|33463005|255765007
in the heart sack|80891009|302509004
)
,
chylothorax|83035003
(chyle|18368008
in the pleural cavity|91381003
)
;
and
chylopericardium|233890005
(chyle|18368008
in the heart sack|80891009|302509004
).

?
*
*ABDOMINAL|277112006
*
* ? Lymphangiomatosis|403546006
has
been
reported|229059009|223458004
in every region|410673009
of the abdomen,|277112006|52731004|302553009
though
the most reported sites|4757001|229059009|10546003|4757001|223458004|10546003
involve|248448006
the intestines|261093006
and
peritoneum|15425007
;
spleen,|78961009|181279003
kidneys,|64033007|17373004
and
liver.|10200004|181268008

Often there|70232002
are
no symptoms
until late|260383002
in the progression|246453008|246450006
of the disease.|64572001

When
they
do
occur|272120004
,
symptoms
include|55919000
abdominal pain|21522001
and/or
distension|25322007
;
nausea,|422587007
vomiting|249497008
,
diarrhea|398032003
;
decreased appetite|64379006
and
malnourishment.

When
the disease|64572001
affects|4065008
the kidneys|64033007|17373004
the symptoms
include|55919000
flank pain,|247355005
abdominal distension,|41931001
blood|87612001|119273009
in the urine,|78014005
and
,
possibly,|60022001
elevated blood pressure,|24184005
which
may
result|394617004
in it
being
confused|286933003
with other cystic renal disease.|74964007|236439005

When
lymphangiomatosis|403546006
occurs|272120004
in the liver|10200004|181268008
and/or
spleen|78961009|181279003
it
may
be
confused|286933003
with polycystic liver disease.|72925005

[11] Symptoms
may
include|55919000
abdominal fullness|277112006|255342004
and
distension|25322007
;
anemia,|271737000
disseminated intravascular coagulopathy (DIC),|65709003|261101003|362970003
fluid accumulation|17672001
in the abdomen|277112006|52731004|302553009
(ascites|271861000
)
,
decreased appetite,|64379006
weight loss,|89362005
fatigue|84229001
;
late findings|260383002|404684003|260383002
include|55919000
liver failure.|59927004

[11] [12]

?
*
*SKELETAL|113192009
*
* ? Symptoms
of lymphangiomatosis|403546006
in the skeletal system|113192009|361378004
are
the same|262126009
as those
of Gorham?s disease.|1515008

Frequently asymptomatic, skeletal lymphangiomatosis|70232002|84387000|113192009|403546006
may
be
discovered
incidentally
or
when
a pathological fracture|268029009
occurs.|272120004

Patients|116154003
may
experience
pain|22253000
of varying severity|272141005
in areas|42798000
around the effected bone.|253861007|272673000|253861007|3138006|253861007|90780006|253861007|128530007

When
the disease|64572001
occurs|272120004
in the bones|272673000|128530007
of the spine,|421060004|44300000|243930007
neurological symptoms|267070008
such as numbness|398026008|44077006
and
tingling|162249002
may
occur|272120004
due to spinal nerve compression.|84116009|3169005|71173004|3169005|263720003|361099009|71173004|361099009|263720003

[13] Progression|246453008|246450006
of disease|64572001
in the spine|421060004|44300000|243930007
may
lead|88488004
to paralysis.|44695005

Lymphangiomatosis|403546006
in conjunction with Chiari I malformation also|253184003|42146005|253184003|22971001
has
been
reported.[14]|229059009|223458004

The cause,|134198009
of lymphangiomatosis|403546006
is
not yet
known.|36692007

As
stated earlier,|398070004|264499004
it
is
generally
considered
to
be
the result|394617004
of congenital errors|6160004|255399007
of lymphatic development|83555006|278923009
occurring|272120004
prior to the 20th week|258705008|259038000
of gestation.|289908002

[4] However,|260308009
the root|85077000|2338009
causes|134198009
of these conditions|260905004
remains
unknown|261665006
and
further research|46053002
is
necessary.

Because
it
is
rare|84638005|103356009
and
has
a wide spectrum|90522003
of clinical, histological,|58147004|67151002
and
imaging features,|363679005|278395004
diagnosing|439401001
lymphangiomatosis|403546006
can
be
challenging.

Plain x-rays|168537006
reveal|263857004
the presence|386397008
of lytic lesions
in bones,|272673000|128530007
pathological fractures,|268029009
interstitial infiltrates|47351003
in the lungs,|39607008
and
chylous effusions|23839001
that
may
be
present|52101004|246105001
even
when
there
are
no outward symptoms.|255543005

[5] [7]|264706000|264605009

The most common locations|4757001|72906007|246267002
of lymphangiomatosis|403546006
are
the lungs|39607008
and
bones|272673000|128530007
and
one important diagnostic clue|421379005|439401001|421379005|261004008
is
the coexistence
of lytic bone lesions|272673000|3138006|90780006|128530007
and
chylous effusion.|23839001

An isolated presentation usually|46651001|246105001
carries|288345009
a better prognosis|3442003|20481000
than
does
multi-organ involvement|278452002
;
the combination|89780004
of pleural|3120008|264148002
and
peritoneal involvement|15425007|248448006|264143006|248448006
with chylous effusions|23839001
and
lytic bone lesions|272673000|3138006|90780006|128530007
carries|288345009
the least favorable prognosis.[16]|276139006|20481000|263796003|20481000

When
lung involvement|39607008|248448006|181216001|248448006
is
suspected,|415684004
high resolution computed tomography (HRCT) scans|75540009|77477000|371879000|77477000
may
reveal|263857004
a diffuse liquid-|19648000|33463005|19648000|264312008
like infiltration|47351003|231287002
in the mediastinal|264099006
and
hilar soft tissue,|181607009
resulting|42752001
from diffuse proliferation|19648000|30217000
of lymphatic channels|83555006|255592004
and
accumulation
of lymphatic fluid|38000004
;
diffuse|19648000
peribronchovascular
and
interlobular septal thickening|255584008|263899003
;
ground-glass opacities|15537006|32039001|125149003|15537006|32039001|128305008
;
and
pleural effusion.|60046008

[1] [17] Pulmonary function testing|260305007
reveals|263857004
either
restrictive pattern|272135003
or
a mixed obstructive/restrictive pattern.|26242008|263821009|272135003

[1] [3]|260305007
While
x-rays,|52250000|168537006
HRCT scan,|373205008
MRI,|113091000
ultrasound,|359659005
lymphangiography,|42687005
bone scan,|41747008
and
bronchoscopy|10847001
all
can
have
a roll
in identifying lymphangiomatosis,|7882003|403546006
biopsy|86273004
remains
the definitive diagnostic tool.|261002007|439401001|86967005|261002007|261004008|86967005

[1] [5] [7] [17] [18] [19]

Microscopic examination|117259009
of biopsy specimens|258415003
reveals|263857004
an increase|260366006
in both
the size|277049003
and
number|410680006|410681005
of thin walled lymphatic channels|18043004|68947003|83555006|255592004
along
with lymphatic spaces|83555006
that
are
interconnecting
and
dilated,|255381004
lined|50009006
by a single attenuated layer|125681006|24588000|50607009|24588000
of endothelial cells|45709008
involving|248448006
the dermis,|53534000
subcutis,|67769002
and
possibly underlying fascia|60022001|84820005|60022001|181772008
and
skeletal muscle.|127954009|244716004

Additionally,
Tazelaar,
et
al.,
described
a pattern|272135003
of histological features|67151002
of lung specimens|39607008|123038009|181216001|123038009
from nine patients|422113007|116154003
in whom
no extrathoracic lesions
were
identified|7882003
,
which
they
termed ?
diffuse|19648000
pulmonary lymphangiomatosis?|39607008|403546006|264164005|403546006
(DPL
).[3]|260313008

Recognition|312020002
of the disease|64572001
requires
a high index|75540009|419205000|371879000|419205000
of suspicion|22927000
and
an extensive workup.|41118005

Because of its serious morbidity,|42745003
lymphangiomatosis|403546006
must
always
be
considered
in the differential diagnosis|47965005
of lytic bone lesions|272673000|3138006|90780006|128530007
accompanied
by chylous effusions,|23839001
in cases|398241000|413769002
of primary chylopericardium,|63161005|233890005|261424001|233890005
and
as part|260726005
of the differential diagnosis|47965005
in pediatric patients|394537008|116154003
presenting|246105001
with signs|72670004
of interstitial lung disease.|51615001|233703007

[18] [20] [21]

There
is
no standard approach
to the treatment|276239002|416118004
of lymphangiomatosis|403546006
and
treatment often|276239002|70232002|416118004|70232002
is
aimed
at reducing symptoms.|260400001

[1] [17] Surgical intervention|260305007|83578000
may
be
indicated|410535002
when
complications|116223007
arise|68727004
and
a number|410680006|410681005
of reports|229059009|223458004
of response
to surgical interventions,|83578000
medications,|410942007
and
dietary approaches|41829006|41829006|103379005
can
be
found|404684003
in the medical literature.|74188005

[1] [17] [16]|260305007

Unfortunately,
there
is
no standardized treatment|276239002|416118004
for lymphangiomatosis|403546006
and
no cure.

Treatment modalities|276239002|416118004
that
have
been
reported|229059009|223458004
in the medical literature,|74188005
by system,|246333005
include|55919000
:

*
*CARDIOTHORACIC
*
* ? Thoracocentesis,|91602002
pericardiocentesis,|309849004
pleurodesis,|84572006
ligation|70751009
of thoracic duct,|1732005
pleuroperitoneal shunt,|442119001|257351008|125319009
radiation therapy,|108290001
pleurectomy,|23979009
pericardial window,|76848001|224755008|76848001|385673002|264135001|224755008|264135001|385673002|224755008|385673002
pericardiectomy,|34646007
thalidomide,|404878004
interferon alpha 2b,|386915008
Total Parenteral Nutrition (TPN),|225372007
medium chain triglyceride (MCT)|420621009
and
high protein diet,|14627000
chemotherapy,|416608005|367336001
sclerotherapy,
transplant|263903005|24486003
;

*
*GASTROINTESTINAL/LIVER/KIDNEY/SPLEEN|10200004|64033007|78961009|10200004|64033007|181279003|10200004|17373004|78961009|10200004|17373004|181279003|10200004|181414000|78961009|10200004|181414000|181279003|181268008|64033007|78961009|181268008|64033007|181279003|181268008|17373004|78961009|181268008|17373004|181279003|181268008|181414000|78961009|181268008|181414000|181279003
*
* ? interferon alpha 2b,|386915008
sclerotherapy,
resection,|118292001|128303001
percutaneous drainage,|103388001|307488001|103388001|122462000
Denver shunt,|257356003
Total Parenteral Nutrition (TPN),|225372007
medium chain triglyceride (MCT)|420621009
and
high protein diet,|14627000
transplant,|263903005|24486003
splenectomy|234319005
;

*
*SKELETON|113192009|361378004
*
* ? interferon alpha 2b,|386915008
bisphosphonates|372907000
(i.e.|42146005|22971001

pamidronate|420442001
)
,
surgical resection,|118292001|128303001
radiation therapy,|108290001
sclerotherapy,
percutaneous bone cement,|103388001|6043006
bone grafts,|80983001|409248003
prosthesis,|53350007|118663006
surgical stabilization.|83578000|115979005

Lymphangiomatosis|403546006
can
occur|272120004
at any age,|424144002
but
the incidence
is
highest|75540009|371879000
in children|410601007|160499008
and
teenagers.|133937008

Signs|72670004
and
symptoms
are
typically
present|52101004|246105001
before the age|424144002
of 20
and
the condition|260905004
is
often|70232002
under-recognized|261089000
in adults.|133936004

[1] [4]|260305007

It
strikes|89098005
males|248153007
and
females|248152002
of all races|415229000
and
exhibits
no inheritance pattern.|246071007|272135003

The medical literature|74188005
contains|42504009
case reports|398241000|229059009|398241000|223458004
from every continent.|261001000|223497007

Because
it
is
so rare,|223528007|84638005|223528007|103356009
and
commonly
misdiagnosed
,
it
is
not
known|36692007
exactly
how
many people|125676002
are
affected|247591002|248448006
by this disease.|64572001

*
*Lymphangiomatosis|403546006
*
*
:
generalized, diffuse,|60132005|19648000
disseminated|65709003
,
multi-organ,|260396001|410653004
pulmonary,|39607008|264164005
thoracic,
cystic,|441457006|20476009
skeletal/extraskeletal, cranial,|113192009|89546000|113192009|66787007
of the bone,|272673000|3138006|90780006|128530007
of the spine,|421060004|44300000|243930007
cervicothorax,
abdominal,|277112006
splenic,|78961009
renal,|64033007
etc.

*
*Vascular Malformation|400159008
*
*
:
vascular anomaly,|400159008
lymphatic malformation|234095009
(microcystic
or
macrocystic
).

Lymphatic malformation (LM)|234095009
is
a classification|73504009
from Mulliken-Glowacki
(1982
)
which
was
adopted|160496001
by the ISSVA
in 1996.

*
*Lymphangioma|400178008
*
*
:
cystic, mesenteric, retroperitoneal, abdominal, vertebral, etc.|441457006|261130005|260642009|277112006|420345000|20476009|261130005|260642009|277112006|420345000

Angioma|400210000
:
angiomatosis,|205562004
hemangioma,|400210000
hemangiomatosis|47669001

*
*Other|74964007
*
*
:
Gorham?s disease,|1515008
Gorham-Stout syndrome,|226507008
disappearing,
vanishing
or
phantom bone disease,|1515008
massive osteolysis There|1515008
is
a great deal|255509001|263768009
of debate
and
confusion|286933003
surrounding|355648006
the terminology
used|394850002
when
a patient|116154003
is
given|419582001
the diagnosis|439401001
of lymphangiomatosis|403546006
(
or
variation|40885006
of the name
).

M
:
VAS|273903006

anat(
a
:
h/u/t/a/l,v:h/u/t/a/l/phys/devp/cell/prot|4421005|304383000|362837007|304383000

noco/syva/cong/lyvd/tumr,
sysi/epon,
injr

proc,
drug|410942007
(C2s+n/3/4/5/7/8/9

